ASCENDIS PHARMA A/S - ADR (ASND) Stock Income Statement
USA - NASDAQ:ASND - US04351P1012 - ADR
216.56 USD
+12.16 (+5.95%)
220 USD
+3.44 (+1.59%)
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 646.55M | 363.64M | 266.72M | 51.17M | 7.78M | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | 85.34M | 44.26M | 44.40M | 12.14M | 3.52M | |||
| Gross Profit | 561.21M | 319.38M | 222.32M | 39.04M | 4.26M | |||
| Operating Expenses | 699.48M | 598.15M | 670.03M | 600.85M | 456.05M | |||
| Research and Development | 292.68M | 299.55M | 395.32M | 368.73M | 285.77M | |||
| Selling, General, and Administrative Expenses | 391.36M | 284.08M | 258.30M | 215.85M | 155.59M | |||
| Operating Income | -138.28M | -278.76M | -447.71M | -561.81M | -451.79M | |||
| Interest Income/Expense | -77.55M | -67.33M | -18.60M | -11.68M | 67.85M | |||
| Other Income/Expense | null | -27.15M | 0 | -4.32M | null | |||
| Non Recurring Items | null | 0 | -7.83M | null | null | |||
| Income Before Taxes | -223.33M | -373.24M | -474.14M | -577.82M | -383.94M | |||
| Income Tax | 9.61M | 4.84M | 7.30M | 5.38M | -370.00K | |||
| Net Income | -232.94M | -378.08M | -481.45M | -583.19M | -383.58M | |||
| EBITDA | -120.93M | -261.05M | -428.80M | -543.86M | -436.39M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.848282400626837 | -6.559163695031921 | -8.590416443229268 | -10.445007951175485 | -7.030293813291191 | |||
| Non GAAP EPS | -3.8600000000000003 | -6.569999999999999 | -8.56 | -10.400000000000002 | -7.01 | |||
| Statistics | ||||||||
| Gross Profit Margin | 86.80% | 87.83% | 83.36% | 76.29% | 54.76% | |||
| Profit Margin | -36.03% | -103.97% | -180.51% | -1139.71% | -4930.33% | |||
| Operating Profit Margin | -21.39% | -76.66% | -167.86% | -1097.93% | -5807.07% | |||
All data in EUR